Global Immuno-oncology Clinical Trials Market Growth (Status and Outlook) 2025-2031

September 2025 | 87 pages | ID: G4E391077056EN
LP Information

Abstracts

According to this study, the global Immuno-oncology Clinical Trials market size will reach US$ million by 2031.

The growth can be attributed to recent developments in immuno-oncology, changes in lifestyle brought on by urbanization predisposing populations to the rise of cancer, and the growing acceptability of targeted therapy.

United States market for Immuno-oncology Clinical Trials is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Immuno-oncology Clinical Trials is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Immuno-oncology Clinical Trials is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Immuno-oncology Clinical Trials players cover Medpace, Novartis, Exscientia, Syneous Health, AstraZeneca, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Immuno-oncology Clinical Trials Industry Forecast” looks at past sales and reviews total world Immuno-oncology Clinical Trials sales in 2024, providing a comprehensive analysis by region and market sector of projected Immuno-oncology Clinical Trials sales for 2025 through 2031. With Immuno-oncology Clinical Trials sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Immuno-oncology Clinical Trials industry.

This Insight Report provides a comprehensive analysis of the global Immuno-oncology Clinical Trials landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Immuno-oncology Clinical Trials portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Immuno-oncology Clinical Trials market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Immuno-oncology Clinical Trials and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Immuno-oncology Clinical Trials.

This report presents a comprehensive overview, market shares, and growth opportunities of Immuno-oncology Clinical Trials market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Phase I
• Phase II
• Phase III
• Phase IV

Segmentation by Application:

• Solid Tumors
• Hematological Cancer

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Medpace
• Novartis
• Exscientia
• Syneous Health
• AstraZeneca
• ICON plc
• IQVIA Holdings
• BioNtech
• Covance, Inc.
• IO BIOTECH

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Immuno-oncology Clinical Trials Market Size (2020-2031)
  2.1.2 Immuno-oncology Clinical Trials Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Immuno-oncology Clinical Trials by Country/Region (2020, 2024 & 2031)
2.2 Immuno-oncology Clinical Trials Segment by Type
  2.2.1 Phase I
  2.2.2 Phase II
  2.2.3 Phase III
  2.2.4 Phase IV
2.3 Immuno-oncology Clinical Trials Market Size by Type
  2.3.1 Immuno-oncology Clinical Trials Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Immuno-oncology Clinical Trials Market Size Market Share by Type (2020-2025)
2.4 Immuno-oncology Clinical Trials Segment by Application
  2.4.1 Solid Tumors
  2.4.2 Hematological Cancer
2.5 Immuno-oncology Clinical Trials Market Size by Application
  2.5.1 Immuno-oncology Clinical Trials Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Immuno-oncology Clinical Trials Market Size Market Share by Application (2020-2025)

3 IMMUNO-ONCOLOGY CLINICAL TRIALS MARKET SIZE BY PLAYER

3.1 Immuno-oncology Clinical Trials Market Size Market Share by Player
  3.1.1 Global Immuno-oncology Clinical Trials Revenue by Player (2020-2025)
  3.1.2 Global Immuno-oncology Clinical Trials Revenue Market Share by Player (2020-2025)
3.2 Global Immuno-oncology Clinical Trials Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 IMMUNO-ONCOLOGY CLINICAL TRIALS BY REGION

4.1 Immuno-oncology Clinical Trials Market Size by Region (2020-2025)
4.2 Global Immuno-oncology Clinical Trials Annual Revenue by Country/Region (2020-2025)
4.3 Americas Immuno-oncology Clinical Trials Market Size Growth (2020-2025)
4.4 APAC Immuno-oncology Clinical Trials Market Size Growth (2020-2025)
4.5 Europe Immuno-oncology Clinical Trials Market Size Growth (2020-2025)
4.6 Middle East & Africa Immuno-oncology Clinical Trials Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Immuno-oncology Clinical Trials Market Size by Country (2020-2025)
5.2 Americas Immuno-oncology Clinical Trials Market Size by Type (2020-2025)
5.3 Americas Immuno-oncology Clinical Trials Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Immuno-oncology Clinical Trials Market Size by Region (2020-2025)
6.2 APAC Immuno-oncology Clinical Trials Market Size by Type (2020-2025)
6.3 APAC Immuno-oncology Clinical Trials Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Immuno-oncology Clinical Trials Market Size by Country (2020-2025)
7.2 Europe Immuno-oncology Clinical Trials Market Size by Type (2020-2025)
7.3 Europe Immuno-oncology Clinical Trials Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Immuno-oncology Clinical Trials by Region (2020-2025)
8.2 Middle East & Africa Immuno-oncology Clinical Trials Market Size by Type (2020-2025)
8.3 Middle East & Africa Immuno-oncology Clinical Trials Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL IMMUNO-ONCOLOGY CLINICAL TRIALS MARKET FORECAST

10.1 Global Immuno-oncology Clinical Trials Forecast by Region (2026-2031)
  10.1.1 Global Immuno-oncology Clinical Trials Forecast by Region (2026-2031)
  10.1.2 Americas Immuno-oncology Clinical Trials Forecast
  10.1.3 APAC Immuno-oncology Clinical Trials Forecast
  10.1.4 Europe Immuno-oncology Clinical Trials Forecast
  10.1.5 Middle East & Africa Immuno-oncology Clinical Trials Forecast
10.2 Americas Immuno-oncology Clinical Trials Forecast by Country (2026-2031)
  10.2.1 United States Market Immuno-oncology Clinical Trials Forecast
  10.2.2 Canada Market Immuno-oncology Clinical Trials Forecast
  10.2.3 Mexico Market Immuno-oncology Clinical Trials Forecast
  10.2.4 Brazil Market Immuno-oncology Clinical Trials Forecast
10.3 APAC Immuno-oncology Clinical Trials Forecast by Region (2026-2031)
  10.3.1 China Immuno-oncology Clinical Trials Market Forecast
  10.3.2 Japan Market Immuno-oncology Clinical Trials Forecast
  10.3.3 Korea Market Immuno-oncology Clinical Trials Forecast
  10.3.4 Southeast Asia Market Immuno-oncology Clinical Trials Forecast
  10.3.5 India Market Immuno-oncology Clinical Trials Forecast
  10.3.6 Australia Market Immuno-oncology Clinical Trials Forecast
10.4 Europe Immuno-oncology Clinical Trials Forecast by Country (2026-2031)
  10.4.1 Germany Market Immuno-oncology Clinical Trials Forecast
  10.4.2 France Market Immuno-oncology Clinical Trials Forecast
  10.4.3 UK Market Immuno-oncology Clinical Trials Forecast
  10.4.4 Italy Market Immuno-oncology Clinical Trials Forecast
  10.4.5 Russia Market Immuno-oncology Clinical Trials Forecast
10.5 Middle East & Africa Immuno-oncology Clinical Trials Forecast by Region (2026-2031)
  10.5.1 Egypt Market Immuno-oncology Clinical Trials Forecast
  10.5.2 South Africa Market Immuno-oncology Clinical Trials Forecast
  10.5.3 Israel Market Immuno-oncology Clinical Trials Forecast
  10.5.4 Turkey Market Immuno-oncology Clinical Trials Forecast
10.6 Global Immuno-oncology Clinical Trials Forecast by Type (2026-2031)
10.7 Global Immuno-oncology Clinical Trials Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Immuno-oncology Clinical Trials Forecast

11 KEY PLAYERS ANALYSIS

11.1 Medpace
  11.1.1 Medpace Company Information
  11.1.2 Medpace Immuno-oncology Clinical Trials Product Offered
  11.1.3 Medpace Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Medpace Main Business Overview
  11.1.5 Medpace Latest Developments
11.2 Novartis
  11.2.1 Novartis Company Information
  11.2.2 Novartis Immuno-oncology Clinical Trials Product Offered
  11.2.3 Novartis Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Novartis Main Business Overview
  11.2.5 Novartis Latest Developments
11.3 Exscientia
  11.3.1 Exscientia Company Information
  11.3.2 Exscientia Immuno-oncology Clinical Trials Product Offered
  11.3.3 Exscientia Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Exscientia Main Business Overview
  11.3.5 Exscientia Latest Developments
11.4 Syneous Health
  11.4.1 Syneous Health Company Information
  11.4.2 Syneous Health Immuno-oncology Clinical Trials Product Offered
  11.4.3 Syneous Health Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Syneous Health Main Business Overview
  11.4.5 Syneous Health Latest Developments
11.5 AstraZeneca
  11.5.1 AstraZeneca Company Information
  11.5.2 AstraZeneca Immuno-oncology Clinical Trials Product Offered
  11.5.3 AstraZeneca Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 AstraZeneca Main Business Overview
  11.5.5 AstraZeneca Latest Developments
11.6 ICON plc
  11.6.1 ICON plc Company Information
  11.6.2 ICON plc Immuno-oncology Clinical Trials Product Offered
  11.6.3 ICON plc Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 ICON plc Main Business Overview
  11.6.5 ICON plc Latest Developments
11.7 IQVIA Holdings
  11.7.1 IQVIA Holdings Company Information
  11.7.2 IQVIA Holdings Immuno-oncology Clinical Trials Product Offered
  11.7.3 IQVIA Holdings Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 IQVIA Holdings Main Business Overview
  11.7.5 IQVIA Holdings Latest Developments
11.8 BioNtech
  11.8.1 BioNtech Company Information
  11.8.2 BioNtech Immuno-oncology Clinical Trials Product Offered
  11.8.3 BioNtech Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 BioNtech Main Business Overview
  11.8.5 BioNtech Latest Developments
11.9 Covance, Inc.
  11.9.1 Covance, Inc. Company Information
  11.9.2 Covance, Inc. Immuno-oncology Clinical Trials Product Offered
  11.9.3 Covance, Inc. Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Covance, Inc. Main Business Overview
  11.9.5 Covance, Inc. Latest Developments
11.10 IO BIOTECH
  11.10.1 IO BIOTECH Company Information
  11.10.2 IO BIOTECH Immuno-oncology Clinical Trials Product Offered
  11.10.3 IO BIOTECH Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 IO BIOTECH Main Business Overview
  11.10.5 IO BIOTECH Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Immuno-oncology Clinical Trials Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Immuno-oncology Clinical Trials Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Phase I
Table 4. Major Players of Phase II
Table 5. Major Players of Phase III
Table 6. Major Players of Phase IV
Table 7. Immuno-oncology Clinical Trials Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 8. Global Immuno-oncology Clinical Trials Market Size by Type (2020-2025) & ($ millions)
Table 9. Global Immuno-oncology Clinical Trials Market Size Market Share by Type (2020-2025)
Table 10. Immuno-oncology Clinical Trials Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 11. Global Immuno-oncology Clinical Trials Market Size by Application (2020-2025) & ($ millions)
Table 12. Global Immuno-oncology Clinical Trials Market Size Market Share by Application (2020-2025)
Table 13. Global Immuno-oncology Clinical Trials Revenue by Player (2020-2025) & ($ millions)
Table 14. Global Immuno-oncology Clinical Trials Revenue Market Share by Player (2020-2025)
Table 15. Immuno-oncology Clinical Trials Key Players Head office and Products Offered
Table 16. Immuno-oncology Clinical Trials Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Immuno-oncology Clinical Trials Market Size by Region (2020-2025) & ($ millions)
Table 20. Global Immuno-oncology Clinical Trials Market Size Market Share by Region (2020-2025)
Table 21. Global Immuno-oncology Clinical Trials Revenue by Country/Region (2020-2025) & ($ millions)
Table 22. Global Immuno-oncology Clinical Trials Revenue Market Share by Country/Region (2020-2025)
Table 23. Americas Immuno-oncology Clinical Trials Market Size by Country (2020-2025) & ($ millions)
Table 24. Americas Immuno-oncology Clinical Trials Market Size Market Share by Country (2020-2025)
Table 25. Americas Immuno-oncology Clinical Trials Market Size by Type (2020-2025) & ($ millions)
Table 26. Americas Immuno-oncology Clinical Trials Market Size Market Share by Type (2020-2025)
Table 27. Americas Immuno-oncology Clinical Trials Market Size by Application (2020-2025) & ($ millions)
Table 28. Americas Immuno-oncology Clinical Trials Market Size Market Share by Application (2020-2025)
Table 29. APAC Immuno-oncology Clinical Trials Market Size by Region (2020-2025) & ($ millions)
Table 30. APAC Immuno-oncology Clinical Trials Market Size Market Share by Region (2020-2025)
Table 31. APAC Immuno-oncology Clinical Trials Market Size by Type (2020-2025) & ($ millions)
Table 32. APAC Immuno-oncology Clinical Trials Market Size by Application (2020-2025) & ($ millions)
Table 33. Europe Immuno-oncology Clinical Trials Market Size by Country (2020-2025) & ($ millions)
Table 34. Europe Immuno-oncology Clinical Trials Market Size Market Share by Country (2020-2025)
Table 35. Europe Immuno-oncology Clinical Trials Market Size by Type (2020-2025) & ($ millions)
Table 36. Europe Immuno-oncology Clinical Trials Market Size by Application (2020-2025) & ($ millions)
Table 37. Middle East & Africa Immuno-oncology Clinical Trials Market Size by Region (2020-2025) & ($ millions)
Table 38. Middle East & Africa Immuno-oncology Clinical Trials Market Size by Type (2020-2025) & ($ millions)
Table 39. Middle East & Africa Immuno-oncology Clinical Trials Market Size by Application (2020-2025) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Immuno-oncology Clinical Trials
Table 41. Key Market Challenges & Risks of Immuno-oncology Clinical Trials
Table 42. Key Industry Trends of Immuno-oncology Clinical Trials
Table 43. Global Immuno-oncology Clinical Trials Market Size Forecast by Region (2026-2031) & ($ millions)
Table 44. Global Immuno-oncology Clinical Trials Market Size Market Share Forecast by Region (2026-2031)
Table 45. Global Immuno-oncology Clinical Trials Market Size Forecast by Type (2026-2031) & ($ millions)
Table 46. Global Immuno-oncology Clinical Trials Market Size Forecast by Application (2026-2031) & ($ millions)
Table 47. Medpace Details, Company Type, Immuno-oncology Clinical Trials Area Served and Its Competitors
Table 48. Medpace Immuno-oncology Clinical Trials Product Offered
Table 49. Medpace Immuno-oncology Clinical Trials Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 50. Medpace Main Business
Table 51. Medpace Latest Developments
Table 52. Novartis Details, Company Type, Immuno-oncology Clinical Trials Area Served and Its Competitors
Table 53. Novartis Immuno-oncology Clinical Trials Product Offered
Table 54. Novartis Immuno-oncology Clinical Trials Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 55. Novartis Main Business
Table 56. Novartis Latest Developments
Table 57. Exscientia Details, Company Type, Immuno-oncology Clinical Trials Area Served and Its Competitors
Table 58. Exscientia Immuno-oncology Clinical Trials Product Offered
Table 59. Exscientia Immuno-oncology Clinical Trials Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 60. Exscientia Main Business
Table 61. Exscientia Latest Developments
Table 62. Syneous Health Details, Company Type, Immuno-oncology Clinical Trials Area Served and Its Competitors
Table 63. Syneous Health Immuno-oncology Clinical Trials Product Offered
Table 64. Syneous Health Immuno-oncology Clinical Trials Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 65. Syneous Health Main Business
Table 66. Syneous Health Latest Developments
Table 67. AstraZeneca Details, Company Type, Immuno-oncology Clinical Trials Area Served and Its Competitors
Table 68. AstraZeneca Immuno-oncology Clinical Trials Product Offered
Table 69. AstraZeneca Immuno-oncology Clinical Trials Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 70. AstraZeneca Main Business
Table 71. AstraZeneca Latest Developments
Table 72. ICON plc Details, Company Type, Immuno-oncology Clinical Trials Area Served and Its Competitors
Table 73. ICON plc Immuno-oncology Clinical Trials Product Offered
Table 74. ICON plc Immuno-oncology Clinical Trials Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 75. ICON plc Main Business
Table 76. ICON plc Latest Developments
Table 77. IQVIA Holdings Details, Company Type, Immuno-oncology Clinical Trials Area Served and Its Competitors
Table 78. IQVIA Holdings Immuno-oncology Clinical Trials Product Offered
Table 79. IQVIA Holdings Immuno-oncology Clinical Trials Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 80. IQVIA Holdings Main Business
Table 81. IQVIA Holdings Latest Developments
Table 82. BioNtech Details, Company Type, Immuno-oncology Clinical Trials Area Served and Its Competitors
Table 83. BioNtech Immuno-oncology Clinical Trials Product Offered
Table 84. BioNtech Immuno-oncology Clinical Trials Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 85. BioNtech Main Business
Table 86. BioNtech Latest Developments
Table 87. Covance, Inc. Details, Company Type, Immuno-oncology Clinical Trials Area Served and Its Competitors
Table 88. Covance, Inc. Immuno-oncology Clinical Trials Product Offered
Table 89. Covance, Inc. Immuno-oncology Clinical Trials Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 90. Covance, Inc. Main Business
Table 91. Covance, Inc. Latest Developments
Table 92. IO BIOTECH Details, Company Type, Immuno-oncology Clinical Trials Area Served and Its Competitors
Table 93. IO BIOTECH Immuno-oncology Clinical Trials Product Offered
Table 94. IO BIOTECH Immuno-oncology Clinical Trials Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 95. IO BIOTECH Main Business
Table 96. IO BIOTECH Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Immuno-oncology Clinical Trials Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Immuno-oncology Clinical Trials Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Immuno-oncology Clinical Trials Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Immuno-oncology Clinical Trials Sales Market Share by Country/Region (2024)
Figure 8. Immuno-oncology Clinical Trials Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Immuno-oncology Clinical Trials Market Size Market Share by Type in 2024
Figure 10. Immuno-oncology Clinical Trials in Solid Tumors
Figure 11. Global Immuno-oncology Clinical Trials Market: Solid Tumors (2020-2025) & ($ millions)
Figure 12. Immuno-oncology Clinical Trials in Hematological Cancer
Figure 13. Global Immuno-oncology Clinical Trials Market: Hematological Cancer (2020-2025) & ($ millions)
Figure 14. Global Immuno-oncology Clinical Trials Market Size Market Share by Application in 2024
Figure 15. Global Immuno-oncology Clinical Trials Revenue Market Share by Player in 2024
Figure 16. Global Immuno-oncology Clinical Trials Market Size Market Share by Region (2020-2025)
Figure 17. Americas Immuno-oncology Clinical Trials Market Size 2020-2025 ($ millions)
Figure 18. APAC Immuno-oncology Clinical Trials Market Size 2020-2025 ($ millions)
Figure 19. Europe Immuno-oncology Clinical Trials Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa Immuno-oncology Clinical Trials Market Size 2020-2025 ($ millions)
Figure 21. Americas Immuno-oncology Clinical Trials Value Market Share by Country in 2024
Figure 22. United States Immuno-oncology Clinical Trials Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada Immuno-oncology Clinical Trials Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico Immuno-oncology Clinical Trials Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil Immuno-oncology Clinical Trials Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC Immuno-oncology Clinical Trials Market Size Market Share by Region in 2024
Figure 27. APAC Immuno-oncology Clinical Trials Market Size Market Share by Type (2020-2025)
Figure 28. APAC Immuno-oncology Clinical Trials Market Size Market Share by Application (2020-2025)
Figure 29. China Immuno-oncology Clinical Trials Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan Immuno-oncology Clinical Trials Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea Immuno-oncology Clinical Trials Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia Immuno-oncology Clinical Trials Market Size Growth 2020-2025 ($ millions)
Figure 33. India Immuno-oncology Clinical Trials Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia Immuno-oncology Clinical Trials Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe Immuno-oncology Clinical Trials Market Size Market Share by Country in 2024
Figure 36. Europe Immuno-oncology Clinical Trials Market Size Market Share by Type (2020-2025)
Figure 37. Europe Immuno-oncology Clinical Trials Market Size Market Share by Application (2020-2025)
Figure 38. Germany Immuno-oncology Clinical Trials Market Size Growth 2020-2025 ($ millions)
Figure 39. France Immuno-oncology Clinical Trials Market Size Growth 2020-2025 ($ millions)
Figure 40. UK Immuno-oncology Clinical Trials Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy Immuno-oncology Clinical Trials Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia Immuno-oncology Clinical Trials Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa Immuno-oncology Clinical Trials Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa Immuno-oncology Clinical Trials Market Size Market Share by Type (2020-2025)
Figure 45. Middle East & Africa Immuno-oncology Clinical Trials Market Size Market Share by Application (2020-2025)
Figure 46. Egypt Immuno-oncology Clinical Trials Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa Immuno-oncology Clinical Trials Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel Immuno-oncology Clinical Trials Market Size Growth 2020-2025 ($ millions)
Figure 49. Turkey Immuno-oncology Clinical Trials Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries Immuno-oncology Clinical Trials Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas Immuno-oncology Clinical Trials Market Size 2026-2031 ($ millions)
Figure 52. APAC Immuno-oncology Clinical Trials Market Size 2026-2031 ($ millions)
Figure 53. Europe Immuno-oncology Clinical Trials Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa Immuno-oncology Clinical Trials Market Size 2026-2031 ($ millions)
Figure 55. United States Immuno-oncology Clinical Trials Market Size 2026-2031 ($ millions)
Figure 56. Canada Immuno-oncology Clinical Trials Market Size 2026-2031 ($ millions)
Figure 57. Mexico Immuno-oncology Clinical Trials Market Size 2026-2031 ($ millions)
Figure 58. Brazil Immuno-oncology Clinical Trials Market Size 2026-2031 ($ millions)
Figure 59. China Immuno-oncology Clinical Trials Market Size 2026-2031 ($ millions)
Figure 60. Japan Immuno-oncology Clinical Trials Market Size 2026-2031 ($ millions)
Figure 61. Korea Immuno-oncology Clinical Trials Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia Immuno-oncology Clinical Trials Market Size 2026-2031 ($ millions)
Figure 63. India Immuno-oncology Clinical Trials Market Size 2026-2031 ($ millions)
Figure 64. Australia Immuno-oncology Clinical Trials Market Size 2026-2031 ($ millions)
Figure 65. Germany Immuno-oncology Clinical Trials Market Size 2026-2031 ($ millions)
Figure 66. France Immuno-oncology Clinical Trials Market Size 2026-2031 ($ millions)
Figure 67. UK Immuno-oncology Clinical Trials Market Size 2026-2031 ($ millions)
Figure 68. Italy Immuno-oncology Clinical Trials Market Size 2026-2031 ($ millions)
Figure 69. Russia Immuno-oncology Clinical Trials Market Size 2026-2031 ($ millions)
Figure 70. Egypt Immuno-oncology Clinical Trials Market Size 2026-2031 ($ millions)
Figure 71. South Africa Immuno-oncology Clinical Trials Market Size 2026-2031 ($ millions)
Figure 72. Israel Immuno-oncology Clinical Trials Market Size 2026-2031 ($ millions)
Figure 73. Turkey Immuno-oncology Clinical Trials Market Size 2026-2031 ($ millions)
Figure 74. Global Immuno-oncology Clinical Trials Market Size Market Share Forecast by Type (2026-2031)
Figure 75. Global Immuno-oncology Clinical Trials Market Size Market Share Forecast by Application (2026-2031)
Figure 76. GCC Countries Immuno-oncology Clinical Trials Market Size 2026-2031 ($ millions)